By Jeff Overley and Cara Salvatore (September 17, 2021, 9:33 p.m. EDT) – A wave of inquiries into misconduct in opioid litigation across the country is rapidly engulfing Endo Pharmaceuticals and threatening to inflict massive damage on the professional reputation of his Arnold & Porter’s attorneys, according to legal documents, court proceedings and interviews.
Increasingly intense investigations focus on the failures of Endo and Arnold & Porter to disclose damaging details about the pharmaceutical company’s marketing of narcotic pain relievers – and whether these discovery gaps were unintentional or intentional.
After clouds first broke earlier this year with a thunderous default judgment linked to discovery errors in Tennessee, the drugmaker and the law …
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
Create personalized alerts for specific case articles and topics and more!